FIELD: chemistry.
SUBSTANCE: invention relates to a method for obtaining a compound of formula I (S)-3-(((((R)-l-(((S)-2-(6-methoxynaphthalen-2-yl)propanoyl)oxy)ethoxy)carbonyl)amino)methyl)-5-methylhexanoic acid. The method involves reaction of (S)-((R,S)-1-((2-fluorophenoxy)carbonyloxy)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate (compound 4) with pregabalin. The invention also relates to (S)-((R,S)-1-((2-fluorophenoxy)carbonyloxy)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate (compound 4) and (R)-1-(((2-fluorophenoxy)carbonyl)oxy)ethyl (S)-2-(6-methoxynaphthalen-2-yl)propanoate (4а).
EFFECT: obtaining (S)-3-(((((R)-l-(((S)-2-(6-methoxynaphthalen-2-yl)propanoyl)oxy)ethoxy)carbonyl)amino)methyl)-5-methylhexanoic acid.
8 cl, 4 dwg, 2 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL METHODS FOR TARGETING CANCER STEM CELLS | 2011 |
|
RU2591823C2 |
NOVEL METHODS FOR TARGETING CANCER STEM CELLS | 2011 |
|
RU2657750C1 |
CRYSTALLINE OR AMORPHOUS FORM OF FXR AGONISTS BEING STEROID DERIVATIVES, THEIR PRODUCTION METHOD AND THEIR USE | 2018 |
|
RU2800751C2 |
CRTH2 ANTAGONIST PARTICLES | 2008 |
|
RU2468012C2 |
NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING AT MALIGNANT STEM CELLS | 2011 |
|
RU2571661C2 |
PHARMACEUTICAL COMPOSITION OF PYRAZOLE COMPOUND DISPERSED IN POLYMER MATRIX | 2020 |
|
RU2826604C1 |
SALTS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASE | 2013 |
|
RU2711077C2 |
PHENYLEPHRINE RESINATE PARTICLES AND USE THEREOF IN PHARMACEUTICAL FORMULATIONS | 2014 |
|
RU2672731C2 |
SOLID DISPERSIONS CONTAINING APOPTOSIS PROMOTING PROTEINS | 2010 |
|
RU2550134C2 |
CRYSTALLINE FORMS OF THE TLR7/TLR8 INHIBITOR | 2019 |
|
RU2792005C2 |
Authors
Dates
2023-07-12—Published
2019-05-14—Filed